Camlin Fine Sciences gets nod to acquire additional 35% stake in subsidiary company

09 Feb 2021 Evaluate

Camlin Fine Sciences has received approval from board of directors for acquisition of 35% stake in its subsidiary namely, Dresen Quimica SAPI de CV (Dresen) from Controladora De Servicios Riso S.A.P.I. de C.V. (the joint venture partner) for  an amount not exceeding $13 million, subject to regulatory  approvals,  if  necessary  and  execution  of  definitive  agreement  by  the  Company  with  the  joint  venture partner. 

Dresen is a joint venture between the Company and Controladora De Servicios Riso S.A.P.I. de C.V. in which the Company currently holds 65% stake.   Post  completion  of  the  said  acquisition, Dresen  will  become  a  wholly?owned  subsidiary  of  the  Company.

Camlin Fine Sciences is the world's second largest manufacturer and marketer of food grade antioxidants BHA (butylated hydroxyanisole) and TBHQ (Tertiary Butylhydroquinone).

Camlin Fine Sciences Share Price

119.95 0.80 (0.67%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Tata Chemicals 1069.40
SRF 2165.85
Pidilite Inds. 2958.60
Aarti Inds 430.80
Atul 7261.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.